| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $71.4M | — | +44.8% |
| Cost of Revenue | $42.5M | — | -14.6% |
| R&D Expense | $62.5M | — | -18.7% |
| SG&A Expense | $38.9M | — | -11.3% |
| Operating Income | -$81.0M | — | +33.1% |
| Pre-tax Income | -$79.7M | — | +32.4% |
| Income Tax | -$665K | — | +63.8% |
| Net Income | -$79.0M | — | +32.0% |
| EPS (Basic) | -$0.19 | — | +47.2% |
| EPS (Diluted) | -$0.19 | — | +47.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $196.5M | +20.5% | +14.5% |
| Short-term Investments | $116.9M | -12.7% | -37.8% |
| Accounts Receivable | $81.8M | -0.8% | +15.3% |
| Inventory | $58.4M | +13.0% | -10.9% |
| Current Assets | $466.5M | +5.4% | -9.0% |
| Total Assets | $925.7M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$72.1M | — | +30.5% |
| Capital Expenditures | $6.6M | — | +6.4% |
| Investing Cash Flow | $11.4M | — | -28.2% |
| Financing Cash Flow | $94.3M | — | -34.2% |
| Free Cash Flow | -$78.7M | — | +28.4% |
| -4.2% |
| Current Liabilities | $129.4M | -6.5% | +5.5% |
| Total Liabilities | $203.9M | -5.0% | +2.5% |
| Stockholders' Equity | $721.8M | +3.3% | -6.0% |